109 related articles for article (PubMed ID: 9112464)
1. Quantification of CCI-103F labeling heterogeneity in canine solid tumors.
Cline JM; Rosner GL; Raleigh JA; Thrall DE
Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):655-62. PubMed ID: 9112464
[TBL] [Abstract][Full Text] [Related]
2. Distribution of the hypoxia marker CCI-103F in canine tumors.
Cline JM; Thrall DE; Rosner GL; Raleigh JA
Int J Radiat Oncol Biol Phys; 1994 Mar; 28(4):921-33. PubMed ID: 8138446
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia marker labeling in tumor biopsies: quantification of labeling variation and criteria for biopsy sectioning.
Thrall DE; Rosner GL; Azuma C; McEntee MC; Raleigh JA
Radiother Oncol; 1997 Aug; 44(2):171-6. PubMed ID: 9288846
[TBL] [Abstract][Full Text] [Related]
4. ELISA quantification of CCI-103F binding in canine tumors prior to and during irradiation.
Thrall DE; McEntee MC; Cline JM; Raleigh JA
Int J Radiat Oncol Biol Phys; 1994 Feb; 28(3):649-59. PubMed ID: 8113108
[TBL] [Abstract][Full Text] [Related]
5. A comparison of oral and intravenous pimonidazole in canine tumors using intravenous CCI-103F as a control hypoxia marker.
Kleiter MM; Thrall DE; Malarkey DE; Ji X; Lee DY; Chou SC; Raleigh JA
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):592-602. PubMed ID: 16289910
[TBL] [Abstract][Full Text] [Related]
6. An enzyme-linked immunosorbent assay for hypoxia marker binding in tumours.
Raleigh JA; La Dine JK; Cline JM; Thrall DE
Br J Cancer; 1994 Jan; 69(1):66-71. PubMed ID: 8286212
[TBL] [Abstract][Full Text] [Related]
7. Prediction of tumor radiosensitivity by hexafluoromisonidazole retention monitored by [1H]/[19F] magnetic resonance spectroscopy.
Li SJ; Jin GY; Moulder JE
Cancer Commun; 1991 May; 3(5):133-9. PubMed ID: 2043424
[TBL] [Abstract][Full Text] [Related]
8. Development of an ELISA for the detection of 2-nitroimidazole hypoxia markers bound to tumor tissue.
Raleigh JA; Zeman EM; Rathman M; LaDine JK; Cline JM; Thrall DE
Int J Radiat Oncol Biol Phys; 1992; 22(3):403-5. PubMed ID: 1310494
[TBL] [Abstract][Full Text] [Related]
9. The relationship between proliferative and oxygenation status in spontaneous canine tumors.
Zeman EM; Calkins DP; Cline JM; Thrall DE; Raleigh JA
Int J Radiat Oncol Biol Phys; 1993 Nov; 27(4):891-8. PubMed ID: 8244820
[TBL] [Abstract][Full Text] [Related]
10. Evaluation and immunohistochemical qualification of carbogen-induced ΔR₂ as a noninvasive imaging biomarker of improved tumor oxygenation.
Baker LC; Boult JK; Jamin Y; Gilmour LD; Walker-Samuel S; Burrell JS; Ashcroft M; Howe FA; Griffiths JR; Raleigh JA; van der Kogel AJ; Robinson SP
Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):160-7. PubMed ID: 23849692
[TBL] [Abstract][Full Text] [Related]
11. Changes in tumor hypoxia measured with a double hypoxic marker technique.
Ljungkvist AS; Bussink J; Rijken PF; Raleigh JA; Denekamp J; Van Der Kogel AJ
Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1529-38. PubMed ID: 11121659
[TBL] [Abstract][Full Text] [Related]
12. Irradiation-dependent effects on tumor perfusion and endogenous and exogenous hypoxia markers in an A549 xenograft model.
Fokas E; Hänze J; Kamlah F; Eul BG; Lang N; Keil B; Heverhagen JT; Engenhart-Cabillic R; An H; Rose F
Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1500-8. PubMed ID: 20637978
[TBL] [Abstract][Full Text] [Related]
13. Distribution of hypoxia and proliferation associated markers in spontaneous canine tumors.
Raleigh JA; Zeman EM; Calkins DP; McEntee MC; Thrall DE
Acta Oncol; 1995; 34(3):345-9. PubMed ID: 7779421
[TBL] [Abstract][Full Text] [Related]
14. Hypoxic cell turnover in different solid tumor lines.
Ljungkvist AS; Bussink J; Kaanders JH; Rijken PF; Begg AC; Raleigh JA; van der Kogel AJ
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1157-68. PubMed ID: 15913908
[TBL] [Abstract][Full Text] [Related]
15. Dynamic measurements of hexafluoromisonidazole (CCI-103F) retention in mouse tumours by 1H/19F magnetic resonance spectroscopy.
Jin GY; Li SJ; Moulder JE; Raleigh JA
Int J Radiat Biol; 1990 Dec; 58(6):1025-34. PubMed ID: 1978851
[TBL] [Abstract][Full Text] [Related]
16. Longevity of pimonidazole adducts in spontaneous canine tumors as an estimate of hypoxic cell lifetime.
Azuma C; Raleigh JA; Thrall DE
Radiat Res; 1997 Jul; 148(1):35-42. PubMed ID: 9216616
[TBL] [Abstract][Full Text] [Related]
17. Quantifying transient hypoxia in human tumor xenografts by flow cytometry.
Bennewith KL; Durand RE
Cancer Res; 2004 Sep; 64(17):6183-9. PubMed ID: 15342403
[TBL] [Abstract][Full Text] [Related]
18. Dynamics of hypoxia, proliferation and apoptosis after irradiation in a murine tumor model.
Ljungkvist AS; Bussink J; Kaanders JH; Wiedenmann NE; Vlasman R; van der Kogel AJ
Radiat Res; 2006 Mar; 165(3):326-36. PubMed ID: 16494521
[TBL] [Abstract][Full Text] [Related]
19. Demonstration of tumor-selective retention of fluorinated nitroimidazole probes by 19F magnetic resonance spectroscopy in vivo.
Maxwell RJ; Workman P; Griffiths JR
Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):925-9. PubMed ID: 2703398
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a fluorinated 2-nitroimidazole binding to hypoxic cells in tumor-bearing rats by 19F magnetic resonance spectroscopy and immunohistochemistry.
Kwock L; Gill M; McMurry HL; Beckman W; Raleigh JA; Joseph AP
Radiat Res; 1992 Jan; 129(1):71-8. PubMed ID: 1728059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
